AC
PALI icon

Armistice Capital’s Palisade Bio PALI Stock Holding History

Armistice Capital’s Portfolio PALI Stock Details PALI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-144,764
Closed -$98.6K – 252
2025
Q1 		$98.6K Buy
144,764
+39,397
+37% +$46.6K ﹤0.01% 202
2024
Q4 		$174K Buy
105,367
+53,367
+103% +$140K ﹤0.01% 196
2024
Q3 		$185K Buy
52,000
+24,142
+87% +$93K ﹤0.01% 220
2024
Q2 		$125K Sell
27,858
-20,142
-42% -$110K ﹤0.01% 219
2024
Q1 		$287K Buy
+48,000
New +$335K ﹤0.01% 245
2019
Q1 		– Sell
-7
Closed -$185K – 80
2018
Q4 		$185K Buy
+7
New +$402K 0.01% 67

Other funds holding PALI

XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
NFSG
Newbridge Financial Services Group Boca Raton, Florida $808M AUM 51.1% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
T
Transce3nd Kyle, Texas $11.3M AUM 16.53% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Armistice Capital's PALI Position: Q2 2025 in Review

Armistice Capital sold out of Palisade Bio (PALI) in Q2 2025, closing a stake of 144,764 shares — an estimated $98.6K sold.

Armistice Capital first reported a position in PALI in Q4 2018 and held it in 6 quarters. The position peaked at $287K in Q1 2024. 11 funds tracked by Wall St. Rank hold PALI as of Q2 2025.

  • Armistice Capital reported no remaining Palisade Bio position as of Q2 2025 after selling out during the quarter.
  • Armistice Capital sold 144,764 Palisade Bio shares in Q2 2025, an estimated $98.6K.
  • Armistice Capital first reported a position in Palisade Bio in Q4 2018 and held it in 6 quarters.
  • Armistice Capital's Palisade Bio position peaked at $287K in Q1 2024.
  • 11 funds tracked by Wall St. Rank held Palisade Bio as of Q2 2025.

Based on Armistice Capital's 13F filing for Q2 2025, filed 14 Aug 2025.